Avalon Investment & Advisory Laboratory Corp Of America Holdings Transaction History

Avalon Investment & Advisory

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 24, 2019	SELL	$123.7 - $156.3 $2.63 Million - $3.33 Million	-21,277 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$120.82 - $174.09 $126,981 - $182,968	1,051 Added 5.2%	21,277 $2.69 Million
Q3 2018 Nov 14, 2018	BUY	$167.67 - $188.27 $237,588 - $266,778	1,417 Added 7.53%	20,226 $3.51 Million
Q2 2018 Aug 14, 2018	BUY	$160.33 - $189.41 $268,873 - $317,640	1,677 Added 9.79%	18,809 $3.38 Million
Q1 2018 Jun 26, 2018	BUY	$161.53 - $178.11 $266,362 - $293,703	1,649 Added 10.65%	17,132 $2.77 Million
Q1 2018 Jun 22, 2018	SELL	$161.53 - $178.11 $266,686 - $294,059	-1,651 Reduced 9.64%	15,483 $2.47 Million
Q1 2018 May 15, 2018	BUY	$161.53 - $178.11 $266,686 - $294,059	1,651 Added 10.66%	17,134 $2.77 Million
Q4 2017 Jun 22, 2018	SELL	$147.99 - $163.95 $8,583 - $9,509	-58 Reduced 0.37%	15,483 $2.47 Million
Q4 2017 Feb 14, 2018	BUY	$147.99 - $163.95 $839,399 - $929,924	5,672 Added 57.47%	15,541 $2.48 Million
Q3 2017 Nov 14, 2017	SELL	$149.47 - $160.56 $1.49 Million - $1.6 Million	-9,941 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	9,941	9,941 $1.53 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.2B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

Stay updated on Avalon Investment & Advisory with notifications on news.